Compare IART & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IART | OCSL |
|---|---|---|
| Founded | 1989 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 1996 | 2007 |
| Metric | IART | OCSL |
|---|---|---|
| Price | $14.92 | $11.71 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 4 |
| Target Price | ★ $14.33 | $12.63 |
| AVG Volume (30 Days) | ★ 1.1M | 750.9K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 12.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.39 | N/A |
| Revenue Next Year | $3.40 | $0.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.70 | $10.63 |
| 52 Week High | $16.42 | $14.77 |
| Indicator | IART | OCSL |
|---|---|---|
| Relative Strength Index (RSI) | 67.71 | 40.37 |
| Support Level | $12.64 | $10.88 |
| Resistance Level | $16.35 | $13.19 |
| Average True Range (ATR) | 0.90 | 0.28 |
| MACD | 0.10 | -0.08 |
| Stochastic Oscillator | 84.02 | 14.07 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.